Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
OSUR

OSUR - OraSure Technologies Inc Stock Price, Fair Value and News

$2.70-0.03 (-1.10%)
Market Closed

52/100

OSUR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

52/100

OSUR

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$2.97

Target 3M

$2.74

Target 6M

$2.81

OSUR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OSUR Price Action

Last 7 days

-2.9%

Last 30 days

11.1%

Trailing 12 Months

-30.9%

OSUR RSI Chart

OSUR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

OSUR Valuation

Market Cap

193.7M

Price/Earnings (Trailing)

-3.22

Price/Sales (Trailing)

1.54

EV/EBITDA

0.5

Price/Free Cashflow

-4.44

OSUR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$2.97

Target 3M

$2.74

Target 6M

$2.81

OSUR Fundamentals

OSUR Revenue

Revenue (TTM)

125.7M

Rev. Growth (Yr)

-32.14%

Rev. Growth (Qtr)

-13.31%

OSUR Earnings

Earnings (TTM)

-60.2M

Earnings Growth (Yr)

-204.24%

Earnings Growth (Qtr)

30.37%

OSUR Profitability

EBT Margin

-44.28%

Return on Equity

-16.64%

Return on Assets

-14.24%

Free Cashflow Yield

-22.54%

OSUR Investor Care

Buy Backs (1Y)

3.83%

Diluted EPS (TTM)

-0.8

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025161.6M138.5M125.7M0
2024304.6M273.5M224.3M185.8M
2023474.7M479.9M452.7M405.5M
2022242.8M265.4M328.0M387.5M
2021198.7M227.1M233.0M233.7M
2020156.1M146.5M158.5M171.7M
2019169.9M165.1M155.2M154.6M
2018176.5M180.0M183.5M181.7M
2017131.7M140.5M150.5M167.1M
2016121.7M122.7M125.1M128.2M
2015110.0M114.0M116.0M119.7M
2014101.3M103.4M106.6M106.5M
201388.0M89.8M92.3M98.9M
201285.4M89.0M89.4M87.8M
201174.5M74.3M77.0M81.9M
201000075.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About OraSure Technologies Inc

OSUR
OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's diagnostic products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene • GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene • GUT DNA and RNA collection devices; and OMNIgene•GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
 CEO
 WEBSITEorasure.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES840

OraSure Technologies Inc Frequently Asked Questions

OSUR is the stock ticker symbol of OraSure Technologies Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of OraSure Technologies Inc is 193.68 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check OSUR's fair value in chart for subscribers.

The fair value guage provides a quick view whether OSUR is over valued or under valued. Whether OraSure Technologies Inc is cheap or expensive depends on the assumptions which impact OraSure Technologies Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OSUR.

As of Wed Jan 28 2026, OSUR's PE ratio (Price to Earnings) is -3.22 and Price to Sales (PS) ratio is 1.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OSUR PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, OraSure Technologies Inc has provided -0.068 (multiply by 100 for percentage) rate of return.